Further evidence does not support hydroxychloroquine for patients with COVID-19
The anti-inflammatory drug hydroxychloroquine does not significantly reduce admission to intensive care or death in patients hospitalized with pneumonia due to COVID-19, finds a study from France. And a randomized clinical trial from China shows that hospitalized patients with mild to moderate persistent covid-19 who received hydroxychloroquine did not clear the virus more quickly than those receiving standard care.
Source: Further evidence does not support hydroxychloroquine for patients with COVID-19
Posted in: AICHC News
Leave a Comment (0) ↓